A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

ACL-508 - Chong Kun Dang, Archela

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants (clinicaltrials.gov) - Feb 28, 2026 - P1 | N=44 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Recruiting ➔ Completed
Trial completion

http://clinicaltrials.gov/ct2/show/NCT06727396

Feb 28, 2026